NGM Biopharmaceuticals, Inc. Stock, NASDAQ:NGM
333 Oyster Point Boulevard, South San Francisco, California 94080-7014
United States of America
Number of Employees: 186
NGM Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for cardio-metabolic, liver, oncologic, and ophthalmic diseases. Its portfolio include aldafermin (NGM282), NGM313, NGM120, NGM217, NGM621, and NGM395. The company was founded by Jin-Long Chen in 2008 and is headquartered in South San Francisco, CA.